Protein may be target for Crohn's therapy | Science News

ADVERTISEMENT

SUPPORT SCIENCE NEWS

Science News is a nonprofit.

Help us keep you informed.


News

Protein may be target for Crohn's therapy

By
12:12pm, October 31, 2001

A protein called MIF–short for macrophage migration inhibitory factor–plays a central role in the process of inflammation. Researchers now report that MIF's actions extend to the intestines. Their findings suggest that the protein perpetuates the chronic inflammation that characterizes Crohn's disease, a painful gut disorder.

In a series of experiments, the scientists induced mice to develop intestinal inflammation, or colitis. While not identical to Crohn's disease in people, this mouse ailment closely mimics it, says study coauthor Cox Terhorst of Beth Israel Deaconess Medical Center in Boston. By giving mice antibodies to MIF, the researchers were able to prevent the disease from setting in and even reverse it in mice that alr

This article is only available to Science News subscribers. Already a subscriber? Log in now. Or subscribe today for full access.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content